🚨 ATTN SfN attendees: Join our pre-SfN event “The Trip between Bedside and Bench: Advancing Cross-Species Translation in Psychedelic Neuroscience.” Limited spots—register now! 👉 hopkinspsychedelic.org/sfn2025

1/ New consensus statement just dropped on the potential for psilocybin in clinical care, from the Task Group on Psychedelics and Related Compounds of the US National Network of Depression Centers The message? Lots of promise, but real risks if we rush. 🧵 authors.elsevier.com/sd/article/S...

🌿 Can psychedelics help with long-COVID & Lyme? Join Dr. Albert Garcia-Romeu (JHU) + an expert panel as they share new research & lived experiences. Free online event! 🔗https://us02web.zoom.us/meeting/register/vg5di-PqS6Ko-GOFOL4Ljg #CPCR #PsychedelicResearch #LongCOVID #LymeDisease

Have you used psychedelics and cannabis on separate occasions? Take our survey! tinyurl.com/psyches-cann... Your responses help advance research on their effects, risks, and benefits.

Microdose interview with Dr. Azin Bekhrad, who runs the Johns Hopkins Clinic for Post-Psychedelic Difficulties themicrodose.substack.com/p/treating-p... (

Our research center is seeking a casual therapist to support cutting-edge studies on the therapeutic effects of psychedelics. Join a team at the forefront of mental health research. Apply below 👇 jobs.jhu.edu/job/Baltimor...

CPCR Faculty David Yaden (@existwell) visited the Uehiro Oxford Institute at Oxford University, advancing work on well-being and the ethics of psychedelics.

Missed our summer newsletter? Catch up on the latest updates from the CPCR and subscribe to stay in the loop: 🔗 hopkinspsychedelic.org/newsletters

Six years ago, our psychedelic center was founded on 20+ years of pioneering research. Today, we’re one of the world’s largest academic hubs in the field—driving innovation, clinical research, and collaboration. Here’s to six years of impact, and many more ahead!

New study from Dr. Brandon Weiss (CPCR) finds UK public attitudes toward psychedelic-assisted therapy are mostly neutral with a slight negative tilt. Published in the International Journal of Drug Policy

Have you used psychedelics and cannabis on separate occasions? Take our survey! tinyurl.com/psyches-cann... Your responses help advance research on their effects, risks, and benefits.

🚨 Research Spotlight 🚨 On Aug 20, Assistant Professor Dr. Brandon Weiss presented to SAMHSA on psychedelic therapeutic models, including his team’s upcoming MDMA + psilocybin trial for PTSD in Veterans.

Check out the latest primer in NPP-Digital Psychiatry and Neuroscience (@dpn_journal), where Dr. Albert Garcia-Romeu explores key debates and unresolved questions in the rapidly evolving field of psychedelic therapy and research. www.nature.com/articles/s44...

Former CPCR postdoc Dr. Jérémie Richard has joined the University of Ottawa as an Assistant Professor in the School of Psychology. He will teach graduate courses in Clinical Psychology and Psychedelic Studies while advancing research on psychedelics and health. Congratulations, Dr. Richard! 🎉

Join us for a webinar with Dr. Albert Garcia-Romeu, presenting on Wednesday, August 20th from 12–1 PM PT, hosted by the USC Institute for Addiction Science in Los Angeles, CA. 📍 Registration is required: us02web.zoom.us/webinar/regi...

The Johns Hopkins Center for Psychedelic and Consciousness Research is committed to public education. Join for Understanding Psychedelic Experiences with Dr. David Yaden at Profs and Pints in Baltimore, MD. 📅 Tue, Aug 19 at 6 PM 📍 The Perch, 1110 S Charles St 🎟️ $13.50 adv | $17 door ($15 student)

📢 Now Recruiting: Research Study on Psilocybin for Depression in Early Alzheimer’s Disease: Psilocybin for depression in early Alzheimer’s/MCI. Receive treatment & free counseling in a safe setting. Sign up: hopkinspsychedelic.org/alzheimers

Do you struggle with chronic low back pain and depression? We are seeking individuals with chronic low back pain and co-occurring depression to see if psilocybin can help! Find out more and click the link below to apply! hopkinspsychedelic.org/backpain

Our research center is seeking a casual therapist to support cutting-edge studies on the therapeutic effects of psychedelics. Join a team at the forefront of mental health research. Apply here 👉 jobs.jhu.edu/job/Baltimor...

Special event Wed 7/30! Dr. David Yaden will discuss the Archives project, where we set out to create the world’s largest database of psychedelic and psychedelic-like experiences, and why this matters! Email Brooklyn Arroyo ([email protected]) to join!

CPCR faculty and postdocs attended an excellent scientific conference on psychedelics at @GordonConf where they presented recent findings. Special thanks to organizers @kwanalexc & @VVyazovskiy #GRCPsychedelics

Experts call for clearer informed consent in psychedelic research as the field grows. A new paper by PhD student Katherine Cheung and CPCR faculty David Yaden urges stronger safeguards to protect participants from complex psychological effects. x.com/Katherine_Ch...

We are seeking veterans who have experience with psilocybin and MDMA to fill out a brief 5-10 minute survey about their experiences. Click the link below to contribute to our research 👇 jhmi.co1.qualtrics.com/jfe/form/SV_...

CPCR faculty David Yaden (@existwell.bsky.social‬) presented and participated in a panel on The Evolving Theory for Explaining Psychedelic Drug Action with Mark Geyer, Harriet de Wit, Franz Vollenweider, Bryan Roth, and Scott Thompson at #GRCPsychedelics

Thrilled to connect at the Neurobiology of Psychedelics Gordon Research Conference next week! CPCR researchers and fellow scientists will discuss wide range of topics, including preclinical and clinical research, drug discovery, and neuroplasticity.

‼️ NEW STUDY FOR HEALTHY VOLUNTEERS ‼️ Join our study at Johns Hopkins exploring how psilocybin affects brain activity and function. Our study uses noninvasive brain imaging methods including EEG, fMRI, TMS, & cognitive testing to better understand effects. Learn more and apply: tinyurl.com/5dc3w4hf

Interested in becoming a psychedelic therapist? We’re seeking a full-time therapist to join our team and support innovative clinical trials exploring the therapeutic potential of psychedelics. Learn more and apply here: jobs.jhu.edu/job/Balitmor...

That’s a wrap on Psychedelic Science 2025! We had a fantastic time presenting our research and connecting with both new and familiar faces in the field. Grateful for the conversations, collaborations, and inspiration. Excited for what’s ahead!

Do you have experience with psychedelic integration? Share your knowledge and experiences in the anonymous questionnaires below to help advance our understanding of how to promote healing, growth, and transformation through psychedelic integration. www.psychedelicintegrationstudies.com

Dr. Brandon Weiss, Assistant Professor, contributed a thoughtful and compassionate perspective to the "Military Voices" panel at last week's Federal Summit on Psychedelic Medicine, which hosted attendees across various sectors including federal policymaking, science, medicine, and industry.

CPCR postdoc Sean Goldy (@seangoldy.bsky.social) spoke at the Centre for Psychedelic Research at Imperial College London and University of Edinburgh, presenting research on psychedelics’ acute subjective effects (e.g., awe), how session facilitators might shape these, and an upcoming trial

Join our brain stimulation research study! Scan the QR code or use the information below to learn more and apply! 410-550-2253 [email protected]

CPCR faculty Dr. Albert Garcia-Romeu was interviewed by Dr. Gillian Beauchamp for the American College of Medical Toxicology's "Tox in Ten" podcast to discuss the history of psychedelic use, current treatment protocols, and research on psychedelics to support recovery from substance use disorders.

Deadline TODAY to apply to Psychedelic Science Postdoctoral Fellowship at the Center for Psychedelic and Consciousness Research with CPCR Faculty David Yaden (@existwell.bsky.social) and Sandeep Nayak. Dual degrees (MD/PhD) preferred–but all excellent candidates considered.

CPCR Associate Center Director Albert Garcia-Romeu will be presenting at the upcoming APA workshop, “The Science of Psychedelics: Research, Risks, and Therapeutic Potentials.” 🔗 Learn more: www.apa.org/events/washi...

CPCR faculty David Yaden (@existwell.bsky.social) spoke with Johns Hopkins Medicine to discuss evidence-based messaging about psychedelic research, informed consent, and adverse events surveillance. Read it here: www.hopkinsmedicine.org/news/article...

CPCR Postdoc Sean Goldy (@seangoldy.bsky.social) presenting on the science of self-transcendence to University College London

Dr. Albert Garcia-Romeu was a guest on the final episode in NPR's Short Wave series on the science behind psychedelics and related drugs: Here's why researchers are making new psychedelic-like drugs — without the trip. www.npr.org/transcripts/...

‼️Excited to speak at this year's @breakingconvention.bsky.social ! I'll cover our work on how much people's subjective effects differ by who guides them, spanning years of clinical trials and hundreds of participants at @JHPsychedelics. First time attending Breaking Convention, too! 👋

RCTs aren't immune to bias—and perceived bias in psychedelic trials is an issue. We propose 4 independence-enhancing practices: - Independent data review - Multisite trials - Quantitative bias analysis - Open Science practices

CPCR Associate Director, Dr. Albert Garcia-Romeu, is presenting on research that investigates the therapeutic potential of psychedelics for chronic illnesses at the uniMIND Symposium in Prague. Visit the link for more details www.mind-foundation.org/event/unimin...

We’re seeking a postdoc with expertise in PTSD and/or Veteran health research, strong publications, and quantitative skills. This fellowship offers experience in clinical drug trials, psilocybin therapy, data analysis, manuscript writing, and grantsmanship.

CPCR Professors Matthew Reid, Brandon Weiss, & colleagues found sleep disturbances decrease post-psilocybin & baseline sleep disturbance severity predicts lower depression remission. Findings suggest sleep interventions may boost antidepressant effects of psilocybin link.springer.com/article/10.1...

CPCR Associate Center Director Dr. Albert Garcia-Romeu was interviewed on Texas Public Radio last week. He discusses how psychedelic research can be supported today. www.tpr.org/podcast/petr...

CPCR Assistant Professor Brandon Weiss and colleagues review the clinical utility of psychedelic therapy for personality disorders, including safety considerations, gaps and limitations, and recommendations. Read more: www.sciencedirect.com/science/arti...

We're hiring a postdoc! Gain experience in clinical trial management, psilocybin therapy, data analysis, writing, and grantsmanship—preparing for an independent clinical science career. Interested applicants may email CV & cover letter to Dr. Brandon Weiss ([email protected]).

CPCR faculty Albert Garcia-Romeu will be presenting TODAY at SXSW at 4pm CST. In a joint session, he will present preliminary findings from a pilot study of psilocybin for post-treatment Lyme Disease. If you’re there, check it out! Visit the link for more details: schedule.sxsw.com/2025/events/...

CPCR faculty Dr. Albert Garcia-Romeu will present preliminary findings from a pilot study of psilocybin for post-treatment Lyme Disease at SXSW in Austin, TX next week in a joint session titled "Beyond the Mind: Psychedelics to Heal the Body." For more info visit: schedule.sxsw.com/2025/events/...

Researchers at Johns Hopkins are seeking volunteers for a ~15 minute survey study about psychedelic experiences among veterans. (Note: if you completed a similar survey 8 months ago, please DO NOT fill out the current survey). To participate, please visit: hopkinspsychedelic.org/veteransurvey

CPCR postdoc Rebecca Ehrenkranz will join a panel on science literacy, public trust in science, and effective methods of communicating research, particularly around controversial or misunderstood topics like psychedelics. This Thursday, March 6th 5-7pm at the MICA Fox Building, Meyerhoff Gallery!